Castanheira M,Mendes RE,Gales AC .2023 .Global epidemiology and mechanisms of resistance of Acinetobacter baumanniicalcoaceticus complex. Clin Infect Dis, 10(Suppl) : S166-78.
Kumar S,Anwer R,Azzi A .2021 .Virulence potential and treatment options of multidrug-resistant (MDR) Acinetobacter baumannii. Microorganisms, 10(10) : 2104.
Ramirez MS,Bonomo RA,Tolmasky ME .2020 .Carbapenemases: Transforming Acinetobacter baumannii into a yet more dangerous menace. Biomolecules, 10(5) : 720.
Jiang Y,Ding Y,Wei Y,Jian C,Liu J .2022 .Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit. Front Microbiol, 1045206 : 1045206.
Isler B,Doi Y,Bonomo RA,Paterson DL .2019 .New treatment options against carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother, 10(1) : 18-8.
Khurshid M,Rasool MH,Ashfaq UA,Aslam B,Waseem M,Xu Q .2020 .-harbouring carbapenem-resistant Acinetobacter baumannii clones in Pakistan. J Glob Antimicrob Resist, 01 : 357-62.
Hamidian M,Nigro SJ .2019 .Emergence, molecular mechanisms and global spread of carbapenem-resistantAcinetobacter baumannii. Microb Genomics, 10(10) : 000306.
.2022 .9. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. CLSI supplement M100, : .
Nordmann P,Sadek M,Tinguely C .2021 .Rapid ResaImi-penem/Acinetobacter NP test for detection of carbapenem susceptibility/resistance in Acinetobacter baumannii. J Clin Microbiol, 10(6) : 25-20.
Khalid F,Saleem S,Ahmad I. .2020 .High prevalence of carbapenem resistant Acinetobacter baumannii associated respiratory tract infections in Pakistani hospitals. J Pak Med Assoc, 10(9) : 1630-2.
Tavasol A,Khademolhosseini S,Noormohamad M,Ghasemi M,Mahram H,Salimi M .2023 .Worldwide prevalence of carbapenem resistance in Acinetobacter baumannii: A systematic review and meta-analysis. Infect Dis Clin Pract, 10(2) : .
.2022 .Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 6736(21) : 02724-0.
Shields RK,Paterson DL,Tamma PD .2023 .Navigating available treatment options for carbapenem-resistantAcinetobacter baumannii-calcoaceticus complex infections. Clin Infect Dis, 10(Suppl 2) : S179-93.
Cavallo I,Oliva A,Pages R,Sivori F,Truglio M,Fabrizio G .2023 .Acinetobacter baumannii in the critically ill: Complex infections get complicated. Front Microbiol, 1196774 : 1196774.
Huang ST,Chiang MC,Kuo SC,Lee YT,Chiang TH,Yang SP .2011 .Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect, 12(5) : 356-62.
Paul M,Carrara E,Retamar P,Tangden T,Bitterman R,Bonomo RA .2021 .European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine. Clin Microbiol Infect, 11(4) : 521-47.
Tamma PD,Aitken SL,Bonomo RA,Mathers AJ,Van Duin D,Clancy CJ .2022 .Infectious Diseases Society of America guidance on the treatment of AmpC ²-lactamase producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. Clin Infect Dis, 10(12) : 2089-114.
Lescat M,Poirel L,Tinguely C .2019 .A resazurin reduction-based assay for rapid detection of polymyxin resistance in Acinetobacter baumannii and Pseudomonas aeruginosa. J Clin Microbiol, 10(3) : 18-18.
Raro OHF,Bouvier M,Kerbol A,Decousser JW,Poirel L,Nordmann P .2023 .Rapid detection of ce derocol susceptibility/resistance in Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis, 10(12) : 1511-8.